Polypharmacy
- Open AccessAttitudes toward medical cannabis among family physicians practising in Ontario, Canada: a qualitative research studyJeremy Y. Ng, Kevin Gilotra, Sana Usman, Yaping Chang and Jason W. BusseApril 13, 2021 9 (2) E342-E348; DOI: https://doi.org/10.9778/cmajo.20200187
- You have accessCharacteristics of high–drug-cost beneficiaries of public drug plans in 9 Canadian provinces: a cross-sectional analysisMina Tadrous, Diana Martins, Muhammad M. Mamdani and Tara GomesApril 28, 2020 8 (2) E297-E303; DOI: https://doi.org/10.9778/cmajo.20190231
- You have accessIntroducing pharmacogenetic testing with clinical decision support into primary care: a feasibility studyMartin Dawes, Martin N. Aloise, J. Sidney Ang, Pieter Cullis, Diana Dawes, Robert Fraser, Gideon Liknaitzky, Andrea Paterson, Paul Stanley, Adriana Suarez-Gonzalez and Hagit Katzov-EckertSeptember 22, 2016 4 (3) E528-E534; DOI: https://doi.org/10.9778/cmajo.20150070
- Clinical
- Anesthesia & Analgesia
- Cardiovascular Medicine
- Complementary Medicine and Alternative Therapies
- Critical Care, Intensive Care
- Drugs
- Emergency Medicine
- Endocrinology & Metabolism
- Environment
- Evidence-based Medicine
- Family Medicine, General Practice, Primary Care
- Gastroenterology
- Genetics
- Geriatric Medicine
- Immunology
- Infectious Diseases
- Lifestyle
- Neurology
- Nutrition & Metabolism
- Obstetrics & Gynecology
- Oncology
- Pathology
- Pediatrics
- Psychiatry
- Public Health
- Radiology
- Rehabilitation Medicine
- Respiratory Medicine (Respirology)
- Rheumatology
- Sexual Medicine
- Surgery
- Women's Health
- Nonclinical
- Epidemiology
- Ethics
- Health Policy
- Journalology
- Management
- Medical Careers
- Medical Education
- Medical Informatics
- Medicare
- Patients